The expanded panel adds 27 HLA-DQ antigens and heterodimer combinations to support more comprehensive antibody assessment in transplant matching and post-transplant monitoring.
Research shows the pTau217 biomarker can identify risk for cognitive decline and amyloid buildup before changes appear on brain scans.
Siemens Healthineers has introduced two new blood-based tau assays for research use on the Atellica platform, expanding its brain health portfolio with tests aimed at advancing neurodegenerative disease research.
Revvity, Inc. has launched the IDS i20, a fully automated, high-throughput platform for ChLIA, enabling labs to consolidate specialty tests.
Diasorin has received FDA 510(k) clearance for its LIAISON PLEX Gram-Positive Blood Culture Assay, completing its syndromic blood culture portfolio.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...